The "Right to Try Clarification Act" is a federal bill aimed at expanding access to experimental treatments for patients with terminal illnesses. The main provisions of the bill include clarifying the process for patients to request access to investigational drugs outside of clinical trials directly from drug manufacturers. This legislation aims to streamline and simplify the existing "Right to Try" law, making it easier for eligible patients to seek potentially life-saving treatments. The bill seeks to provide hope and additional options for individuals facing serious health conditions by facilitating their access to experimental therapies that have not yet received full approval from the FDA.
2023-03-28: Introduced in House
2023-03-28: Sponsor introductory remarks on measure. (CR E267)
2023-03-28: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2023-04-07: Referred to the Subcommittee on Health.
Contribute Your Insights: Add a Unique Perspective to Political Bills. Your Contribution will be Featured Below the Primary Bill, Ordered by Date Added.
No Reviews found ..